Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467089 · ClinicalTrials.gov registry record
The Assessment of Movement Disorders Utilizing Live Two-Way Video
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 37
- Enrollment target
NCT01467089: Completed study, sponsored by Northwell Health.
NCT01467089 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01467089 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person
Interventions
- OTHER Two way video assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-06 |
What the finished NCT01467089 record still lists
NCT01467089 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Two way video assessment is the first listed.
NCT01467089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01467089 about?
NCT01467089 is a clinical study titled "The Assessment of Movement Disorders Utilizing Live Two-Way Video". The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person
What is the current status of trial NCT01467089?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2011-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01467089?
The interventions under investigation include: Two way video assessment (OTHER).
Who is sponsoring clinical trial NCT01467089?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia